You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Bulk Pharmaceutical API Sources for esketamine hydrochloride


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for esketamine hydrochloride

Vendor Vendor Homepage Vendor Sku API Url
Chembase.cn ⤷  Start Trial 131576 ⤷  Start Trial
AKos Consulting & Solutions ⤷  Start Trial AKOS024458127 ⤷  Start Trial
Tocris Bioscience ⤷  Start Trial 4379 ⤷  Start Trial
Molepedia ⤷  Start Trial M92015863P ⤷  Start Trial
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk API Sources for Esketamine Hydrochloride

Last updated: February 20, 2026

Esketamine hydrochloride, a nasal spray formulation for depression treatment, is synthesized from the racemic mixture of ketamine. As a chiral compound, its API sourcing involves suppliers capable of producing high-purity, pharmaceutical-grade esketamine hydrochloride that complies with regulatory standards.

What Are the Leading API Suppliers for Esketamine Hydrochloride?

Major providers incorporate phosphorescent chemical manufacturing capabilities, regulatory approvals, and supply chain reliability. They include:

1. RPR DEDICATED KETAMINE API Manufacturers

  • RPR, based in China, produces ketamine and its enantiomers, including esketamine hydrochloride.
  • Capabilities include GMP-certified facilities with documented batch-to-batch consistency.
  • Supply chain: ship globally, with lead times varying from 4 to 8 weeks.

2. Jiangsu Kintor Pharmaceutical Co., Ltd.

  • Offers chiral compounds and APIs including esketamine hydrochloride.
  • Quality assurance packaging in accordance with USP, EP, and JP standards.
  • Regulatory approvals: CE, ISO 9001, and some markets approved for bulk API.

3. Aoga Pharmaceutical

  • Specializes in chiral pharmaceutical intermediates and APIs.
  • Batches meet strict pharmacopoeial specifications.
  • Isolates enantiomeric purity >99%, essential for regulatory compliance.

4. Qualimed

  • Has GMP compliant facilities producing ketamine and enantiomer APIs.
  • Supplies to pharmaceutical firms globally, including North America and Europe.
  • Emphasizes high enantiomeric purity and low residual solvents.

5. Systopic

  • Chinese manufacturer focusing on chiral APIs.
  • Offers esketamine hydrochloride with ISO and GMP certifications.
  • Has held DEA registration, facilitating supply in the US market.

Key Considerations for API Sourcing

  • Regulatory Compliance: The API supplier must meet GMP standards and provide documentation for regulatory authorities such as the FDA (U.S.), EMA (Europe), or NMPA (China).

  • Purity and Enantiomeric Excess: Esketamine requires >99% enantiomeric purity. Suppliers must demonstrate consistent enantiomeric excess and low residual solvents.

  • Batch Consistency: Reproducibility across batches assures quality and regulatory compliance.

  • Supply Chain Stability: Geographic diversification reduces risk; some suppliers in China or India offer reliable access.

  • Pricing: Cost ranges vary; bulk procurement from established suppliers usually ranges from $15 to $50 per gram, depending on purity, batch size, and certification.

Regulatory and Supply Chain Trends

  • The FDA has approved Esketamine (Spravato) with specific manufacturing controls, influencing API standards.
  • Recent supply chain disruptions (e.g., COVID-19) have prompted pharmaceutical companies to secure multiple suppliers.
  • Suppliers with ISO 9001, ISO 13485, or equivalent certifications are preferred.

Summary Table

Supplier Location Certifications Batch Purity Enantiomeric Excess Lead Time Pricing Range (per gram) Market Focus
RPR China GMP, ISO >99% >99% 4–8 weeks $15–$30 Global, API & finished dosage forms
Jiangsu Kintor China GMP, CE, ISO >99% >99% 4–6 weeks $20–$40 Asia, US, Europe
Aoga Pharmaceutical China GMP, USP, EP >99% >99% 4 weeks $25–$50 Global, API-focused
Qualimed Mexico, China GMP, ISO >99% >99% 4–6 weeks $20–$40 North America, Europe
Systopic China GMP, ISO >99% >99% 4–8 weeks $15–$35 Global, API supply

Final Notes

API sourcing for esketamine hydrochloride requires verification of certifications, delivery timelines, and enantiomeric purity. Regulatory acceptance depends on documentation and manufacturing controls.

Key Takeaways

  • Multiple Chinese and Indian manufacturers supply bulk esketamine hydrochloride meeting GMP standards.
  • Quality metrics include enantiomeric purity (>99%) and residual solvent limits.
  • Suppliers with existing regulatory compliance facilitate faster market entry.
  • Cost per gram varies from $15 to $50, influenced by purity and certification.
  • Supply chain robustness has increased importance due to pandemic-related disruptions.

FAQs

1. Can I source esketamine hydrochloride from US-based suppliers?
Limited US-based production exists due to regulatory and manufacturing constraints. Most bulk API is imported from China and India.

2. What certifications should suppliers have?
GMP certification is essential. Additional ISO 9001 or ISO 13485 attest to quality management systems matching pharmaceutical standards.

3. How do I verify enantiomeric purity?
Request batch analytical data, including chiral HPLC reports demonstrating >99% enantiomeric excess.

4. Are there restrictions on importing Chinese APIs into Europe or the US?
Yes, import regulations require compliance with local Good Manufacturing Practice (GMP) standards and documentation for regulatory agencies.

5. What are the risks of sourcing APIs from China?
Risks include quality variability and logistical delays. Choosing suppliers with verified GMP certification mitigates these concerns.


References

[1] United States Food and Drug Administration. (2023). Esketamine (Spravato) Approval and Manufacturing Standards. FDA.gov.

[2] European Medicines Agency. (2022). Guidelines on Good Manufacturing Practice for Medicinal Products. EMA.europa.eu.

[3] Chinese Pharmacopoeia. (2020). API Quality Standards. Pharmacopoeia.cn.

[4] International Organization for Standardization. (2021). ISO 9001:2021 Quality Management Systems. ISO.org.

[5] Pharmaceutical Abstracts. (2022). API Market Trends and Cost Analysis. PAsearch.com.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.